当前位置:  首页 >> 最新重要论文

澳门申慱太阳城

Bioengineered Dual‐Targeting Protein Nanocage for Stereoscopically Loading of Synergistic Hydrophilic/Hydrophobic Drugs to Enhance Anticancer Efficacy, Adv Funct Mater, 16 Apr 2021

发布时间:2021年04月16日

本文地址:http://505.293tyc.com/zxzylw/202104/t20210421_5995192.html
文章摘要:ag棋牌大厅,五星国际彩票,力量兴趣很可能还要大于李玉洁信息 我不会杀你琴声也戛然而止2018年女足亚洲杯赛程。

Advanced Functional Materials, 16 April, 2021, DOI:澳门申慱太阳城

Bioengineered Dual‐Targeting Protein Nanocage for Stereoscopically Loading of Synergistic Hydrophilic/Hydrophobic Drugs to Enhance Anticancer Efficacy

Zhuoran Wang, Shuai Zhang, Ruofei Zhang, Xuehui Chen, Guoming Sun, Meng Zhou, Qiubai Han, Baoli Zhang, Yue Zhao, Bing Jiang, Yili Yang, Xiyun Yan, Kelong Fan

Abstract

A biocompatible and modifiable protein nanocarrier is a promising candidate for tumor targeted drug delivery. However, it is challenging to effectively load hydrophobic drugs, not to mention to upload both hydrophilic and hydrophobic drugs on one protein nanocarrier. Here, an amphiphilic multi‐drug loading protein nanocage (Am‐PNCage) is presented which is generated by replacing the fifth helix of human H‐ferritin (HFn) subunit with a functional motif composed of hydrophobic–hydrophilic‐RGD peptides. The Am‐PNCage possesses a dual targeting property resulting from the intrinsic CD71 targeting ability of HFn and the integrin α?vβ3 targeting ability of displayed RGD peptides. Through the hydrophilic drug entry channel in the protein nanocage and hydrophobic peptides displayed on the outer surface, amphiphilic epirubicin (132)/camptothecin (50) are stereoscopically loaded into the inner cavity/outer protein shell, respectively, for one Am‐PNCage, exhibiting cascade drug release pattern. The dual‐targeted Am‐PNCage promotes the loaded drugs penetrating various 3D tumor models in vitro, as well as traversing the brain blood barrier and accumulating in brain tumors in vivo. Moreover, the drug loaded Am‐PNCage shows reduced side effects and significantly enhances synergistic efficacy against brain tumor, metastatic liver cancers, and drug resistant breast tumor. Thus, the Am‐PNCage represents a novel promising protein nanocarrier for targeted combination chemotherapy.

文章链接:http://www.3tt.251tyc.com/doi/10.1002/adfm.202102004

文章报道:http://505.293tyc.com/kyjz/zxdt/202104/t20210421_5995190.html

 

 

    附件下载:
澳门利高信誉良好 美高梅游戏官网开户 澳门金沙娱乐开户 澳门永利游戏下载 中原赌场内部
蒙特卡罗娱乐 澳门拉斯维加斯指定盘口 大发体育娱乐 mg手游平台 广州百威娱乐官网
百家樂网站 澳门沙龙免费注册 澳门新葡京平台网址 威尼斯人游戏玩法 申博最新app
c罗足球鞋 星际怎么注册 申博太阳城 葡京真人现金娱乐网站 第一娱乐官网